Literature DB >> 11960346

Migratory behavior of leukemic cells from acute myeloid leukemia patients.

C Voermans1, W P M van Heese, I de Jong, W R Gerritsen, C E van Der Schoot.   

Abstract

The chemokine stromal cell-derived factor-1 (SDF-1) and its receptor CXCR-4 contribute to stem cell homing and may play a role in the trafficking of leukemic cells. Therefore, we analyzed migration across Transwell filters of cells derived from bone marrow (BM) or peripheral blood (PB) from 26 acute myeloid leukemia (AML) patients. The presence of the extracellular matrix protein fibronectin (FN) strongly enhanced the spontaneous and SDF-1-induced migration of leukemic PB and BM cells. No differences in spontaneous, SDF-1-induced migration or CXCR-4 expression were observed between the different AML subtypes. Subsequently, it was determined whether SDF-1 preferentially promoted migration of subsets of leukemic cells. Leukemic cells expressing CD34, CD38 and HLA-DR were preferentially migrating, whereas cells expressing CD14 and CD36 showed diminished migration. Analysis of paired PB and BM samples indicated that significantly higher SDF-1-induced migration was observed in AML for CD34(+) BM-derived cells compared to CD34(+) PB-derived cells, suggesting a role for SDF-1 in the anchoring of leukemic cells in the BM or other organs. The lower percentage of circulating leukemic blasts in patients with a relatively high level of SDF-1-induced migration also supports this hypothesis. In conclusion, we have shown that primary AML cells are migrating towards SDF-1 independent of the AML subtypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960346     DOI: 10.1038/sj.leu.2402431

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  33 in total

Review 1.  Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches.

Authors:  Marina Konopleva; Yoko Tabe; Zhihong Zeng; Michael Andreeff
Journal:  Drug Resist Updat       Date:  2009-07-25       Impact factor: 18.500

2.  Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies.

Authors:  Vilma Oliveira Frick; Claudia Rubie; Pirus Ghadjar; Sabrina K Faust; Mathias Wagner; Stefan Gräber; Martin K Schilling
Journal:  Tumour Biol       Date:  2010-09-24

3.  Stromal-derived factor-1 and its receptor, CXCR4, are constitutively expressed by mouse liver sinusoidal endothelial cells: implications for the regulation of hematopoietic cell migration to the liver during extramedullary hematopoiesis.

Authors:  Mayela Mendt; Jose E Cardier
Journal:  Stem Cells Dev       Date:  2012-01-26       Impact factor: 3.272

4.  Homing of cancer cells to the bone.

Authors:  Anjali Mishra; Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Cancer Microenviron       Date:  2011-08-09

5.  Internal tandem duplication mutations in FLT3 gene augment chemotaxis to Cxcl12 protein by blocking the down-regulation of the Rho-associated kinase via the Cxcl12/Cxcr4 signaling axis.

Authors:  Chie Onishi; Chie Onish; Satomi Mori-Kimachi; Tomohiro Hirade; Mariko Abe; Takeshi Taketani; Junji Suzumiya; Toshitsugu Sugimoto; Seiji Yamaguchi; Reuben Kapur; Seiji Fukuda
Journal:  J Biol Chem       Date:  2014-09-18       Impact factor: 5.157

6.  Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells.

Authors:  Jane L Liesveld; Jeremy Bechelli; Karen Rosell; Chaohui Lu; Gary Bridger; Gordon Phillips; Camille N Abboud
Journal:  Leuk Res       Date:  2007-04-02       Impact factor: 3.156

7.  BIGH3 modulates adhesion and migration of hematopoietic stem and progenitor cells.

Authors:  Sofieke E Klamer; Carlijn G M Kuijk; Peter L Hordijk; C Ellen van der Schoot; Marieke von Lindern; Paula B van Hennik; Carlijn Voermans
Journal:  Cell Adh Migr       Date:  2013-10-08       Impact factor: 3.405

Review 8.  Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

Authors:  Hyunsuk Shim; Shinya Oishi; Nobutaka Fujii
Journal:  Semin Cancer Biol       Date:  2008-11-25       Impact factor: 15.707

9.  CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia.

Authors:  L Brault; A Rovó; S Decker; C Dierks; A Tzankov; J Schwaller
Journal:  Leukemia       Date:  2013-07-02       Impact factor: 11.528

10.  Tumor biology and cancer therapy - an evolving relationship.

Authors:  Thomas Seufferlein; Johann Ahn; Denis Krndija; Ulrike Lother; Guido Adler; Götz von Wichert
Journal:  Cell Commun Signal       Date:  2009-08-13       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.